Omnicell Inc reports results for the quarter ended in September 30 - Earnings Summary

Omnicell

30/10/2024 15:11

* Omnicell Inc  OMCL.OQ  reported quarterly adjusted
earnings of
56 cents​​ per share for the quarter ended September 30, lower
than the same quarter last year, when the company reported EPS
of 62 cents.  The mean expectation of nine analysts for the
quarter was for earnings of 40 cents per share. Wall Street
expected results to range from 34 cents to 47 cents per share.
    * Revenue fell 5.4% to $282.42 million from a year ago;
analysts
expected $280.45 million. 
    * Omnicell Inc's reported EPS for the quarter was 19 cents​.
    * The company reported quarterly net income of $8.63
million.
    * Omnicell Inc shares had fallen by 8.0% this quarter and
gained 6.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Omnicell Inc is
$44.50 
This summary was machine generated from LSEG data October 30 at
03:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.40           0.56           Beat
 Jun. 30 2024      0.14           0.51           Beat
 Mar. 31 2024      -0.09          0.03           Beat
 Dec. 31 2023      0.15           0.33           Beat